Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.64	43.48	24.23	34.95	144.51
Short-Term Investments	178.26	83.24	128.23	151.66	-
Cash & Short-Term Investments	208.91	126.72	152.46	186.61	144.51
Cash Growth	64.85%	-16.88%	-18.30%	29.13%	206.98%
Other Current Assets	0.91	6.03	1.42	8.18	2.59
Total Current Assets	209.82	132.75	153.88	194.79	147.11
Net Property, Plant & Equipment	9.45	7.3	2.67	4.53	6.33
Other Long-Term Assets	0.32	0.35	0.32	0.32	0.32
Total Assets	219.59	140.4	156.88	199.65	153.76
Accounts Payable	1.59	2.25	4.09	3.38	0.87
Accrued Expenses	11.38	6.29	2.51	11.69	8.78
Current Portion of Leases	1	0.34	1.2	1.1	0.99
Total Current Liabilities	13.97	8.87	7.8	16.17	10.63
Long-Term Leases	8.83	6.3	0.54	1.84	3.05
Total Long-Term Liabilities	8.83	6.3	0.54	1.84	3.05
Total Liabilities	22.8	15.17	8.34	18.01	13.68
Common Stock	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	627.67	489.69	463.8	454.74	373.66
Accumulated Other Comprehensive Income	0.28	0.21	0.04	-0.3	-
Retained Earnings	-431.17	-364.68	-315.31	-272.81	-233.59
Shareholders' Equity	196.79	125.23	148.54	181.64	140.08
Total Liabilities & Equity	219.59	140.4	156.88	199.65	153.76
Total Debt	9.83	6.63	1.73	2.94	4.04
Net Cash (Debt)	199.08	120.09	150.73	183.67	140.48
Net Cash Growth	65.78%	-20.33%	-17.94%	30.75%	272.20%
Net Cash Per Share	1.26	0.87	1.19	1.75	2.23
Book Value	196.79	125.23	148.54	181.64	140.08
Book Value Per Share	1.25	0.91	1.17	1.73	2.23
Tangible Book Value	196.79	125.23	148.54	181.64	140.08
Tangible Book Value Per Share	1.25	0.91	1.17	1.73	2.23

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q